Quick Answer
SINOVAC BIOTECH LTD reported Research And Development Expense of $344.52 million for the year ending 2023.
- SINOVAC BIOTECH LTD showed a decrease of -22.1% in Research And Development Expense from 2022 to 2023.
- This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
- XBRL data for this metric is available from 2009 to 2023 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2009 to 2023), SINOVAC BIOTECH LTD's Research And Development Expense has grown by 7,719.9%.
- Historical annual values: Fiscal year 2023: $344.52 million | Fiscal year 2022: $442.11 million | Fiscal year 2021: $155.04 million | Fiscal year 2020: $48.76 million | Fiscal year 2019: $24.25 million | Fiscal year 2018: $21.91 million | Fiscal year 2017: $20.49 million | Fiscal year 2016: $12.65 million | Fiscal year 2015: $9.49 million | Fiscal year 2014: $10.93 million | Fiscal year 2013: $8.13 million | Fiscal year 2012: $17.04 million | Fiscal year 2011: $9.01 million | Fiscal year 2010: $8.51 million | Fiscal year 2009: $4.41 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: